1. Home
  2. INUV vs INKT Comparison

INUV vs INKT Comparison

Compare INUV & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$3.04

Market Cap

49.8M

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$12.20

Market Cap

57.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
INKT
Founded
N/A
2017
Country
United States
United States
Employees
N/A
23
Industry
Advertising
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.8M
57.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
INUV
INKT
Price
$3.04
$12.20
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$14.00
$35.00
AVG Volume (30 Days)
229.6K
11.7K
Earning Date
02-26-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$98,139,861.00
N/A
Revenue This Year
$20.86
N/A
Revenue Next Year
$14.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.11
N/A
52 Week Low
$2.34
$4.56
52 Week High
$6.27
$76.00

Technical Indicators

Market Signals
Indicator
INUV
INKT
Relative Strength Index (RSI) 54.31 54.15
Support Level $2.74 $11.28
Resistance Level $3.80 $12.31
Average True Range (ATR) 0.26 0.49
MACD 0.01 0.04
Stochastic Oscillator 41.26 78.87

Price Performance

Historical Comparison
INUV
INKT

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: